A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Lumenis Launches MOSES™ HoLEP University to Help Urologists Master the Gold-Standard Laser Treatment for Enlarged Prostate

What To Know

  • Accessed on demand, MOSES HoLEP University's 14 modules explain how to perform different HoLEP techniques, including morcellation strategies, as well as how to set up a HoLEP practice, troubleshoot, and manage patient follow-up and concerns.
  • Lumenis, the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, today announced the launch of a comprehensive global educational platform called MOSES HoLEP University that will enable urologists to offer their patients holmium laser enucleation of the prostate (HoLEP) with MOSES, the gold-standard treatment for enlarged prostate (benign prostatic hyperplasia, or BPH).

Lumenis, the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, today announced the launch of a comprehensive global educational platform called MOSES HoLEP University that will enable urologists to offer their patients holmium laser enucleation of the prostate (HoLEP) with MOSES, the gold-standard treatment for enlarged prostate (benign prostatic hyperplasia, or BPH).

By making HoLEP training available to any urologist at any time, the program will fill an educational gap. While interest in the procedure is expanding by 8% to 12% per year,1 opportunities for training remain limited due to restricted hospital foot traffic and travel during the COVID-19 pandemic.2

Lumenis responded to this demand for HoLEP education by joining forces with world-renowned physicians and BPH specialists Dr. Amy Krambeck of Northwestern Medicine and Dr. Tim Large of Indiana University Health. With help from Dr. Large, Dr. Krambeck will lead a one-of-a-kind opportunity for surgeons to master HoLEP through MOSES HoLEP University, an online, on-demand, module-based educational platform. Surgeons will observe a HoLEP procedure step by step, allowing them to achieve a full understanding of the technique. Training will be free to Lumenis customers using MOSES laser technology, winner of the prestigious Silver 2021 Medical Design Excellence Award in Gastrointestinal and Genitourinary Devices.

“MOSES HoLEP University was designed to facilitate more comprehensive learning with a faster learning curve,”3 said Dr. Krambeck. “Training will support urologists’ ability to effectively and efficiently perform HoLEP in men with BPH, regardless of their prostate size4 or history of taking blood thinners.”5

Accessed on demand, MOSES HoLEP University’s 14 modules explain how to perform different HoLEP techniques, including morcellation strategies, as well as how to set up a HoLEP practice, troubleshoot, and manage patient follow-up and concerns. In addition, trainees are invited to attend a MOSES Mastery course for hands-on lab and simulation experience. Following completion of MOSES HoLEP University, physicians can become adept at the HoLEP technique after 20 to 30 supervised procedures.6 In the future, each participant will be assigned a HoLEP mentor who can assist remotely with challenges.

HoLEP is a trusted procedure that has been improved by Lumenis MOSES technology. The Lumenis Pulse 120H laser with MOSES 2.0 technology shortens HoLEP procedure time by 20%, increases the rate of enucleation efficiency by 67%, and minimizes bleeding by 30%.7 As a result, more than 90% of patients can go home the same day, catheter-free,8 and only 0.7% of patients need retreatment in the next 10 years.9 MOSES has won multiple awards as a groundbreaking medical technology that is changing patient care.

“We are extremely proud to introduce this first-of-its-kind educational opportunity for surgeons who want to learn HoLEP with our breakthrough MOSES laser technology,” said Lumenis CEO Tzipi Ozer-Armon. “With unparalleled mentorship from recognized experts, MOSES HoLEP University will help surgeons satisfy patient demand for this important treatment, provide superior clinical outcomes, and elevate their practices.”


References:

1. IQVIA™ Hospital Procedures & Diagnosis US claims data coverage 2017-2019 (inpatient & outpatient).

2. Adopting Gold-Standard Procedures During COVID-19 – Patient Safety & Quality Healthcare (psqh.com).

3. Krambeck AE, Large T. Urology. 2020;136:196-201.

4. Elzayat EA, et al. Urology. 2005;66(5):108-113.

5. The HoLEP Procedure – Advanced Urology Institute – (auinstitute.com).

6. El-Hakim A., et al. BJU Int. 2002;90(9):863-9.

7. Kavoussi NL, et al. J Urol. 2021;206(1):104-108.8. Agarwal DK, et al. Eur Urol Focus. 2021 Jan 4.

8. Agarwal DK, et al. Eur Urol Focus. 2021 Jan 4.

9. Elmansy HM, et al. J Urol. 2011;186(5):1972-1976.

SourceLumenis
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Reeva FT is offered in a variety of sizes: 2x2 cm, 2x3 cm, 4x4 cm, 4x6 cm, 4x8 cm, and 10x15 cm. Reeva FT is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.
The study is designed to assess the clinical utility and workflow benefits of Swoop® system images acquired at infusion centers and clinics to help physicians detect amyloid-related imaging abnormalities (ARIA) in Alzheimer’s patients receiving amyloid-targeting therapy at the times specified in the labeling (before the fifth, seventh, and fourteenth infusions).
“Tom and I have more than 50 years of experience,” Harp adds. “The decision to found Polymer Medical was done after careful consideration of the landscape and market opportunity; we will raise the level of competition and quality for customers.” Polymer Medical is located in a newly refurbished plant is at 168 Thorn Ave., Orchard Park, N.Y.
The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.
Details of the session: Polaroid Therapeutics & Avery Dennison Medical: How the power of partnership brings a novel approach to antimicrobial wound dressings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy